Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Schwarcz, Erik"" wg kryterium: Autor


Tytuł :
Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2Antibodies.
Autorzy :
Pörksen, Sven
Laborie, Lene Bjerke
Nielsen, Lotte
Andersen, Marie Louise Max
Sandal, Tone
de Wet, Heidi
Schwarcz, Erik
Åman, Jan
Swift, Peter
Kocova, Mirjana
Schönle, Eugen J.
de Beaufort, Carine
Hougaard, Philip
Ashcroft, Frances
Molven, Anders
Knip, Mikael
Mortensen, Henrik B.
Hansen, Lars
Njølstad, Pål R.
Pokaż więcej
Temat :
DISEASE progression
DIABETES in children
IMMUNOGLOBULINS
GLUTAMIC acid
GENETIC mutation
XENOPUS
Źródło :
BMC Endocrine Disorders; 2010, Vol. 10, p16-25, 10p
Czasopismo naukowe
Tytuł :
Sustained Intensive Treatment and Long-term Effects on HbA 1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI.
Autorzy :
Lind M; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden .; Department of Medicine, NU-Hospital Group, Uddevalla, Sweden.
Ólafsdóttir AF; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; Department of Medicine, NU-Hospital Group, Uddevalla, Sweden.
Hirsch IB; University of Washington School of Medicine, Seattle, WA.
Bolinder J; Department of Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
Dahlqvist S; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.
Pivodic A; Statistiska Konsultgruppen, Gothenburg, Sweden.; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Hellman J; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Wijkman M; Department of Internal Medicine and Department of Health, Medicine and Caring Sciences, Linköping University, Norrköping, Sweden.
Schwarcz E; Department of Internal Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Albrektsson H; Statistiska Konsultgruppen, Gothenburg, Sweden.
Heise T; Profil, Neuss, Germany.
Polonsky W; Department of Medicine, University of California, San Diego, La Jolla, CA.; Behavioral Diabetes Institute, San Diego, CA.
Pokaż więcej
Źródło :
Diabetes care [Diabetes Care] 2021 Jan; Vol. 44 (1), pp. 141-149. Date of Electronic Publication: 2020 Nov 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The Association Between HbA 1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4).
Autorzy :
Seyed Ahmadi S; Department of Medicine, NU-Hospital Group, Trollhättan/Uddevalla, Sweden .; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.
Westman K; Department of Medicine, NU-Hospital Group, Trollhättan/Uddevalla, Sweden.; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.
Pivodic A; Statistiska Konsultgruppen, Gothenburg, Sweden.; Department of Ophthalmology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Ólafsdóttir AF; Department of Medicine, NU-Hospital Group, Trollhättan/Uddevalla, Sweden.; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.
Dahlqvist S; Department of Medicine, NU-Hospital Group, Trollhättan/Uddevalla, Sweden.
Hirsch IB; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA.
Hellman J; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Ekelund M; Type 1 Diabetes & Functional Insulins, Novo Nordisk A/S, Søborg, Denmark.
Heise T; Profil, Neuss, Germany.
Polonsky W; Department of Medicine, University of California, San Diego, La Jolla, CA.; Behavioral Diabetes Institute, San Diego, CA.
Wijkman M; Department of Internal Medicine and Department of Health, Medicine and Caring Sciences, Linköping University, Norrköping, Sweden.
Schwarcz E; Department of Medicine, Örebro University Hospital, Örebro, Sweden.
Lind M; Department of Medicine, NU-Hospital Group, Trollhättan/Uddevalla, Sweden.; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.
Pokaż więcej
Źródło :
Diabetes care [Diabetes Care] 2020 Sep; Vol. 43 (9), pp. 2017-2024. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 1/*blood
Diabetes Mellitus, Type 1/*drug therapy
Glycated Hemoglobin A/*analysis
Hypoglycemia/*blood
Insulin/*administration & dosage
Adult ; Blood Glucose/analysis ; Blood Glucose/drug effects ; Blood Glucose Self-Monitoring ; Cross-Over Studies ; Drug Administration Schedule ; Female ; Glycated Hemoglobin A/drug effects ; Glycated Hemoglobin A/metabolism ; Humans ; Hypoglycemia/chemically induced ; Hypoglycemia/pathology ; Injections, Subcutaneous ; Insulin/adverse effects ; Male ; Middle Aged ; Sweden ; Time Factors
Czasopismo naukowe
Tytuł :
Excess Morbidity Persists in Patients With Cushing's Disease During Long-term Remission: A Swedish Nationwide Study.
Autorzy :
Papakokkinou E; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; The Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Olsson DS; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; The Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Chantzichristos D; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; The Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Dahlqvist P; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Segerstedt E; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Olsson T; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Petersson M; Department of Molecular Medicine and Surgery, Karolinska Institutet and The Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Berinder K; Department of Molecular Medicine and Surgery, Karolinska Institutet and The Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Bensing S; Department of Molecular Medicine and Surgery, Karolinska Institutet and The Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Höybye C; Department of Molecular Medicine and Surgery, Karolinska Institutet and The Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Edén-Engström B; Department of Medical Sciences; Endocrinology, Diabetes and Metabolism, Uppsala University Hospital, Uppsala, Sweden.
Burman P; Department of Endocrinology, Skåne University Hospital, University of Lund, Malmö, Sweden.
Bonelli L; Department of Endocrinology, Skåne University Hospital, University of Lund, Malmö, Sweden.
Follin C; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Petranek D; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Erfurth EM; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Wahlberg J; Department of Endocrinology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Ekman B; Department of Endocrinology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Åkerman AK; Department of Internal Medicine, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Schwarcz E; Department of Internal Medicine, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Bryngelsson IL; Department of Occupational and Environmental Medicine, University Hospital, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Johannsson G; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; The Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Ragnarsson O; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; The Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Pokaż więcej
Źródło :
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Aug 01; Vol. 105 (8).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Pituitary ACTH Hypersecretion/*epidemiology
Sepsis/*epidemiology
Stroke/*epidemiology
Thromboembolism/*epidemiology
Adult ; Aged ; Comorbidity ; Female ; Follow-Up Studies ; Fractures, Bone/epidemiology ; Glucocorticoids/therapeutic use ; Humans ; Incidence ; Male ; Medical Records/statistics & numerical data ; Middle Aged ; Neoplasms/epidemiology ; Pituitary ACTH Hypersecretion/drug therapy ; Remission Induction ; Retrospective Studies ; Risk Factors ; Sweden/epidemiology
Czasopismo naukowe
Tytuł :
Changing diagnostic criteria for gestational diabetes in Sweden - a stepped wedge national cluster randomised controlled trial - the CDC4G study protocol.
Autorzy :
Fadl H; Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. .
Saeedi M; Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Montgomery S; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.; Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Epidemiology and Public Health, University College London, London, UK.
Magnuson A; Clinical Epidemiology and Biostatistics, University Hospital Örebro, Örebro, Sweden.
Schwarcz E; Department of Internal Medicine, School of medical health and sciences, Örebro University Hospital, Örebro, Sweden.
Berntorp K; Department of Endocrinology, Skåne University Hospital, Clinical Research Center Malmö, Lund University, Lund, Sweden.
Sengpiel V; Department of Obstetrics and Gynaecology, Sahlgrenska University Hospital, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Storck-Lindholm E; Department of Obstetrics and Gynaecology, Södersjukhuset, Stockholm, Sweden.
Strevens H; Department of Obstetrics and Gynaecology, Skåne University Hospital, Clinical Research Center Lund, Lund University, Lund, Sweden.
Wikström AK; Women's and Children's Health, Uppsala university, Uppsala, Sweden.
Brismar-Wendel S; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
Persson M; Department of Paediatrics, Sachsska Children's and Youth hospital and Department of Clinical Science and Education, Karolinska Institute, Stockholm, Sweden.
Jansson S; School of Medical Sciences, University Health Care Research Center, Örebro University, Örebro, Sweden.
Ahlsson F; Department of Women's and Children's health, Uppsala University, Uppsala, Sweden.
Ursing C; Department of Endocrinology, Södersjukhuset, Stockholm, Sweden.
Ryen L; Center for Health Care Science, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Petersson K; Department of Clinical Sciences, Obstetrics and Gynaecology, Umeå University, Umeå, Sweden.
Wennerholm UB; Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Hildén K; Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Simmons D; Macarthur Clinical School, Western Sydney University, Campbell town, Australia.; Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Pokaż więcej
Źródło :
BMC pregnancy and childbirth [BMC Pregnancy Childbirth] 2019 Nov 01; Vol. 19 (1), pp. 398. Date of Electronic Publication: 2019 Nov 01.
Typ publikacji :
Clinical Trial Protocol; Journal Article
MeSH Terms :
Practice Guidelines as Topic*
Diabetes, Gestational/*diagnosis
Prenatal Diagnosis/*standards
Adult ; Cluster Analysis ; Female ; Humans ; Pregnancy ; Pregnancy Outcome ; Prospective Studies ; Randomized Controlled Trials as Topic ; Sweden
Czasopismo naukowe
Tytuł :
Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study.
Autorzy :
Ragnarsson O; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden.
Olsson DS; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden.
Papakokkinou E; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden.
Chantzichristos D; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden.
Dahlqvist P; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Segerstedt E; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Olsson T; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Petersson M; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Berinder K; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Bensing S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Höybye C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Edén-Engström B; Department of Medical Sciences; Endocrinology, Diabetes and Metabolism, Uppsala University Hospital, Uppsala, Sweden.
Burman P; Department of Endocrinology, Skåne University Hospital, University of Lund, Malmö, Sweden.
Bonelli L; Department of Endocrinology, Skåne University Hospital, University of Lund, Malmö, Sweden.
Follin C; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Petranek D; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Erfurth EM; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Wahlberg J; Department of Endocrinology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Ekman B; Department of Endocrinology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Åkerman AK; Department of Internal Medicine, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Schwarcz E; Department of Internal Medicine, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Bryngelsson IL; Department of Occupational and Environmental Medicine, Örebro University Hospital, Örebro, Sweden.
Johannsson G; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden.
Pokaż więcej
Źródło :
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2019 Jun 01; Vol. 104 (6), pp. 2375-2384.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Pituitary ACTH Hypersecretion/*mortality
Adult ; Cardiovascular Diseases/mortality ; Female ; Hormone Replacement Therapy ; Humans ; Male ; Middle Aged ; Pituitary ACTH Hypersecretion/therapy ; Proportional Hazards Models ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The incidence of Cushing's disease: a nationwide Swedish study.
Autorzy :
Ragnarsson O; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, and The Department of Endocrinology, Sahlgrenska University Hospital, Gröna Stråket 8, 413 45, Gothenburg, Sweden. .
Olsson DS; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, and The Department of Endocrinology, Sahlgrenska University Hospital, Gröna Stråket 8, 413 45, Gothenburg, Sweden.
Chantzichristos D; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, and The Department of Endocrinology, Sahlgrenska University Hospital, Gröna Stråket 8, 413 45, Gothenburg, Sweden.
Papakokkinou E; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, and The Department of Endocrinology, Sahlgrenska University Hospital, Gröna Stråket 8, 413 45, Gothenburg, Sweden.
Dahlqvist P; Department of Medicine, Umeå University, 901 87, Umeå, Sweden.
Segerstedt E; Department of Medicine, Umeå University, 901 87, Umeå, Sweden.
Olsson T; Department of Medicine, Umeå University, 901 87, Umeå, Sweden.
Petersson M; Patient Area Endocrinology and Nephrology, Inflammation and Infection Theme, Karolinska University Hospital, 171 76, Solna, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 77, Stockholm, Sweden.
Berinder K; Patient Area Endocrinology and Nephrology, Inflammation and Infection Theme, Karolinska University Hospital, 171 76, Solna, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 77, Stockholm, Sweden.
Bensing S; Patient Area Endocrinology and Nephrology, Inflammation and Infection Theme, Karolinska University Hospital, 171 76, Solna, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 77, Stockholm, Sweden.
Höybye C; Patient Area Endocrinology and Nephrology, Inflammation and Infection Theme, Karolinska University Hospital, 171 76, Solna, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 77, Stockholm, Sweden.
Edén Engström B; Department of Medical Sciences, Endocrinology, Diabetes and Metabolism, Uppsala University Hospital, 751 85, Uppsala, Sweden.
Burman P; Department of Endocrinology, Skåne University Hospital, 214 28, Malmö, Sweden.; University of Lund, 223 50, Lund, Sweden.
Bonelli L; Department of Endocrinology, Skåne University Hospital, 214 28, Malmö, Sweden.; University of Lund, 223 50, Lund, Sweden.
Follin C; Department of Endocrinology, Skåne University Hospital, 222 42, Lund, Sweden.
Petranek D; Department of Endocrinology, Skåne University Hospital, 222 42, Lund, Sweden.
Erfurth EM; Department of Endocrinology, Skåne University Hospital, 222 42, Lund, Sweden.
Wahlberg J; Department of Endocrinology, Department of Medical and Health Sciences, Linköping University, 581 83, Linköping, Sweden.
Ekman B; Department of Endocrinology, Department of Medical and Health Sciences, Linköping University, 581 83, Linköping, Sweden.
Åkerman AK; Department of Internal Medicine, School of Medical Sciences, Örebro University, 702 81, Örebro, Sweden.
Schwarcz E; Department of Internal Medicine, School of Medical Sciences, Örebro University, 702 81, Örebro, Sweden.
Bryngelsson IL; Department of Occupational and Environmental Medicine, Örebro University Hospital, 702 81, Örebro, Sweden.
Johannsson G; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, and The Department of Endocrinology, Sahlgrenska University Hospital, Gröna Stråket 8, 413 45, Gothenburg, Sweden.
Pokaż więcej
Źródło :
Pituitary [Pituitary] 2019 Apr; Vol. 22 (2), pp. 179-186.
Typ publikacji :
Journal Article
MeSH Terms :
Cushing Syndrome/*epidemiology
Pituitary ACTH Hypersecretion/*epidemiology
Adrenocorticotropic Hormone/blood ; Cohort Studies ; Cushing Syndrome/blood ; Humans ; Hydrocortisone/blood ; Incidence ; Pituitary ACTH Hypersecretion/blood ; Sweden/epidemiology
Czasopismo naukowe
Tytuł :
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).
Autorzy :
Ólafsdóttir AF; 1 Department of Medicine, NU - Hospital Group, Trollhättan /Uddevalla, Sweden .; 2 Department of Molecular and Clinical Medicine, University of Gothenburg , Gothenburg, Sweden .
Polonsky W; 3 Department of Psychiatry, University of California , San Diego, California.
Bolinder J; 4 Department of Medicine, Karolinska University Hospital Huddinge , Karolinska Institutet, Stockholm, Sweden .
Hirsch IB; 5 School of Medicine, University of Washington , Seattle, Washington.
Dahlqvist S; 1 Department of Medicine, NU - Hospital Group, Trollhättan /Uddevalla, Sweden .
Wedel H; 6 Health Metrics Sahlgrenska Academy, University of Gothenburg , Gothenburg, Sweden .
Nyström T; 7 Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet , Stockholm, Sweden .
Wijkman M; 8 Department of Internal Medicine and Department of Medical and Health Sciences, Linköping University , Norrköping, Sweden .
Schwarcz E; 9 Department of Internal Medicine, Faculty of Medicine and Health, Örebro University , Örebro, Sweden .
Hellman J; 10 Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University , Uppsala, Sweden .
Heise T; 11 Profil , Neuss, Germany .
Lind M; 1 Department of Medicine, NU - Hospital Group, Trollhättan /Uddevalla, Sweden .; 2 Department of Molecular and Clinical Medicine, University of Gothenburg , Gothenburg, Sweden .
Pokaż więcej
Źródło :
Diabetes technology & therapeutics [Diabetes Technol Ther] 2018 Apr; Vol. 20 (4), pp. 274-284. Date of Electronic Publication: 2018 Apr 02.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Blood Glucose/*analysis
Diabetes Mellitus, Type 1/*blood
Hypoglycemia/*blood
Hypoglycemic Agents/*therapeutic use
Insulin/*therapeutic use
Adult ; Blood Glucose Self-Monitoring ; Cross-Over Studies ; Diabetes Mellitus, Type 1/drug therapy ; Female ; Glycated Hemoglobin A/analysis ; Humans ; Hypoglycemia/chemically induced ; Hypoglycemic Agents/adverse effects ; Insulin/adverse effects ; Male ; Middle Aged ; Quality of Life
Czasopismo naukowe
Tytuł :
Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.
Autorzy :
Burman P
Edén-Engström B; Department of EndocrinologySkane University Hospital Malmö, University of Lund, 20502 Malmö, SwedenDepartment of DiabetesEndocrinology and Metabolism, University Hospital, Uppsala University, Uppsala, SwedenDepartments of Endocrinology and Medical and Health SciencesLinköping University, Linköping, SwedenDepartment of Internal MedicineFaculty of Medicine and Health, Örebro University, Örebro, Sweden.
Ekman B; Department of EndocrinologySkane University Hospital Malmö, University of Lund, 20502 Malmö, SwedenDepartment of DiabetesEndocrinology and Metabolism, University Hospital, Uppsala University, Uppsala, SwedenDepartments of Endocrinology and Medical and Health SciencesLinköping University, Linköping, SwedenDepartment of Internal MedicineFaculty of Medicine and Health, Örebro University, Örebro, Sweden.
Karlsson FA; Department of EndocrinologySkane University Hospital Malmö, University of Lund, 20502 Malmö, SwedenDepartment of DiabetesEndocrinology and Metabolism, University Hospital, Uppsala University, Uppsala, SwedenDepartments of Endocrinology and Medical and Health SciencesLinköping University, Linköping, SwedenDepartment of Internal MedicineFaculty of Medicine and Health, Örebro University, Örebro, Sweden.
Schwarcz E; Department of EndocrinologySkane University Hospital Malmö, University of Lund, 20502 Malmö, SwedenDepartment of DiabetesEndocrinology and Metabolism, University Hospital, Uppsala University, Uppsala, SwedenDepartments of Endocrinology and Medical and Health SciencesLinköping University, Linköping, SwedenDepartment of Internal MedicineFaculty of Medicine and Health, Örebro University, Örebro, Sweden.
Wahlberg J; Department of EndocrinologySkane University Hospital Malmö, University of Lund, 20502 Malmö, SwedenDepartment of DiabetesEndocrinology and Metabolism, University Hospital, Uppsala University, Uppsala, SwedenDepartments of Endocrinology and Medical and Health SciencesLinköping University, Linköping, SwedenDepartment of Internal MedicineFaculty of Medicine and Health, Örebro University, Örebro, Sweden.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2016 Jan; Vol. 174 (1), pp. 17-24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Dopamine Agonists/*therapeutic use
Ergolines/*therapeutic use
Pituitary ACTH Hypersecretion/*drug therapy
Adrenocorticotropic Hormone/blood ; Adult ; Aged ; Cabergoline ; Circadian Rhythm ; Ergolines/administration & dosage ; Female ; Humans ; Hydrocortisone/analysis ; Hydrocortisone/blood ; Hydrocortisone/urine ; Male ; Middle Aged ; Prospective Studies ; Saliva/chemistry
Czasopismo naukowe
Tytuł :
Randomized controlled study in pregnancy on treatment of marked hyperglycemia that is short of overt diabetes.
Autorzy :
Fadl HE; Department of Obstetrics and Gynecology, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Gärdefors S; Department of Obstetrics and Gynecology, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Hjertberg R; UltraGyn Clinic, Stockholm, Sweden.
Nord E; Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden.
Persson B; Karolinska Institute, Stockholm, Sweden.
Schwarcz E; Department of Internal Medicine, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Åman J; Department of Pediatrics, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Östlund IK; Department of Obstetrics and Gynecology, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Hanson US; Department of Obstetrics and Gynecology, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.; Department of Children's and Women's Health, Uppsala University, Uppsala, Sweden.
Pokaż więcej
Źródło :
Acta obstetricia et gynecologica Scandinavica [Acta Obstet Gynecol Scand] 2015 Nov; Vol. 94 (11), pp. 1181-7. Date of Electronic Publication: 2015 Aug 29.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Birth Weight*
Hyperglycemia/*drug therapy
Prediabetic State/*drug therapy
Pregnancy Complications/*blood
Pregnancy Complications/*drug therapy
Adult ; Blood Glucose/analysis ; Fasting ; Female ; Glucose Tolerance Test ; Humans ; Hypoglycemic Agents/therapeutic use ; Infant, Newborn ; Insulin/therapeutic use ; Pregnancy ; Single-Blind Method
Czasopismo naukowe
Tytuł :
Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells.
Autorzy :
Carlsson PO; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden Department of Medical Sciences, Uppsala University, Uppsala, Sweden .
Schwarcz E; Department of Internal Medicine, Örebro University Hospital, Örebro, Sweden.
Korsgren O; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Le Blanc K; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło :
Diabetes [Diabetes] 2015 Feb; Vol. 64 (2), pp. 587-92. Date of Electronic Publication: 2014 Sep 09.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Mesenchymal Stem Cell Transplantation*
Diabetes Mellitus, Type 1/*metabolism
Insulin-Secreting Cells/*physiology
Mesenchymal Stem Cells/*physiology
Adult ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł :
Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies.
Autorzy :
Pörksen S; Department of Pediatrics, Glostrup Hospital & University of Copenhagen, Copenhagen, Denmark. .
Laborie LB
Nielsen L
Louise Max Andersen M
Sandal T
de Wet H
Schwarcz E
Aman J
Swift P
Kocova M
Schönle EJ
de Beaufort C
Hougaard P
Ashcroft F
Molven A
Knip M
Mortensen HB
Hansen L
Njølstad PR
Pokaż więcej
Corporate Authors :
Hvidøre Study Group on Childhood Diabetes
Źródło :
BMC endocrine disorders [BMC Endocr Disord] 2010 Sep 23; Vol. 10, pp. 16. Date of Electronic Publication: 2010 Sep 23.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies